Eastside Research Associates Health Research

Redmond, Washington 98052

1 studies enrolling now · 2 studies all time

What they study most

Obesity or Overweight, Type 2 Diabetes Mellitus (T2DM)

Studies at this site

• Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH) — Recruiting now
• A Study of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus (T2DM) — Running, not enrolling